Letter by Kan et al regarding Article, "randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart failure (WATCH) trial"

Circulation. 2009 Nov 17;120(20):e164. doi: 10.1161/CIRCULATIONAHA.109.882308.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Aspirin / administration & dosage
  • Chronic Disease
  • Clopidogrel
  • Death
  • Double-Blind Method
  • Female
  • Fibrinolytic Agents / administration & dosage*
  • Heart Failure / complications
  • Heart Failure / drug therapy*
  • Heart Failure / mortality
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction
  • Stroke
  • Stroke Volume
  • Ticlopidine / administration & dosage
  • Ticlopidine / analogs & derivatives
  • Warfarin / administration & dosage

Substances

  • Fibrinolytic Agents
  • Warfarin
  • Clopidogrel
  • Ticlopidine
  • Aspirin